Try our Advanced Search for more refined results
March 03, 2014
Amarin Pharmaceuticals Ireland Limited v. Omthera Pharmaceuticals Inc. et al
Case Number:
1:14-cv-00279
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 04, 2014
Amarin Targets AstraZeneca In Suit Over Heart Medication
Amarin Pharmaceuticals Ireland Ltd. on Tuesday hit AstraZeneca Pharmaceuticals LP with a lawsuit alleging that the company's heart medication Epanova will infringe on Amarin's patent for Vascepa, marking the second lawsuit within a week the company has filed to protect its rights to the triglyceride-reducing drug.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login